Treatment options for hypertension in pregnancy and puerperium

被引:20
作者
Amro, Farah H. [1 ]
Moussa, Hind N. [2 ]
Ashimi, Olaide A. [2 ]
Sibai, Baha M. [2 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Dept Obstet Gynecol & Reprod Sci, Houston, TX 77030 USA
[2] Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, Houston, TX USA
关键词
Antihypertensives; chronic hypertension; drugs; gestational hypertension; labetalol; methyldopa; nifedipine; preeclampsia; preeclampsia with severe features; pregnancy; teratogenesis; PERINATAL OUTCOMES; ANGIOGENIC FACTORS; PRETERM BIRTH; TIGHT CONTROL; LESS-TIGHT; PREECLAMPSIA; NIFEDIPINE; LABETALOL; DISORDERS; MANAGEMENT;
D O I
10.1080/14740338.2016.1237500
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Introduction: Hypertensive disorders have become increasingly prevalent and complicate an increasing number of pregnancies. Therefore it is essential that the medications used to treat these disorders be well understood. Furthermore the management is complicated by special consideration needed for the physiologic changes of pregnancy as well as the consideration for possible adverse fetal effects. Areas covered: We performed a review of the scientific literature of medications used to treat hypertensive disorders in pregnancy. We reviewed the guidelines used by different societies all over the world. We also discussed the pharmacodynamics, pharmacokinetics and possible adverse effects relating to the antihypertensive medications. Finally, we discussed the long-term maternal implications of these diseases. Expert opinion: Overall, we encourage a step-wise approach to treating hypertensive disorders of pregnancy. While making sure to max out the use of one medications prior to shifting to another. Also, it is imperative not to be aggressive with treatment due to risk of compromising utero-placental blood flow. There is research currently involving biomarkers, nano-medicine and the placenta project with hopes of developing new targeted medications with a good fetal safety profile.
引用
收藏
页码:1635 / 1642
页数:8
相关论文
共 42 条
[1]
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy [J].
Abalos, Edgardo ;
Duley, Lelia ;
Steyn, D. Wilhelm .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (02)
[2]
Global and regional estimates of preeclampsia and eclampsia: a systematic review [J].
Abalos, Edgardo ;
Cuesta, Cristina ;
Grosso, Ana L. ;
Chou, Doris ;
Say, Lale .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 170 (01) :1-7
[3]
Effect of Pregnancy on the Pharmacokinetics of Antihypertensive Drugs [J].
Anderson, Gail D. ;
Carr, Darcy B. .
CLINICAL PHARMACOKINETICS, 2009, 48 (03) :159-168
[4]
[Anonymous], 2003, COCHRANE DB SYST REV
[5]
[Anonymous], 2014, MEDICATIONS MOTHERS
[6]
Maternal Preeclampsia and Neonatal Outcomes [J].
Backes, Carl H. ;
Markham, Kara ;
Moorehead, Pamela ;
Cordero, Leandro ;
Nankervis, Craig A. ;
Giannone, Peter J. .
JOURNAL OF PREGNANCY, 2011, 2011 :214365
[7]
Nifedipine administered in pregnancy: effect on the development of children at 18 months [J].
Bortolus, R ;
Ricci, E ;
Chatenoud, L ;
Parazzini, F .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2000, 107 (06) :792-794
[8]
A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy [J].
Clark, Shannon M. ;
Dunn, Holly E. ;
Hankins, Gary D. V. .
SEMINARS IN PERINATOLOGY, 2015, 39 (07) :548-555
[9]
COCKBURN J, 1982, LANCET, V1, P647
[10]
Risk of congenital malformations among infants exposed to antidepressants during pregnancy [J].
Davis, Robert L. ;
Andrade, Susan ;
Platt, Richard .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (04) :423-423